An improved method for rapid and efficient radioiodination of iodine-123-IQNB

Journal of Nuclear Medicine

Volumn 37, Issue 12, 1996, Pages 2021-2024

  Lee, Kan Sam ^a   He, Xiao Shu ^b   Jones, Douglas W ^b   Coppola, Richard ^b   Gorey, Julia G ^b   Knable, Michael B ^b   DeCosta, Brian R ^b   Rice, Kenner C ^b   Weinberger, Daniel R ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NONE

Author keywords

Diastereomers; Iodine 123 IQNB; Muscarinic receptors; SPECT

Indexed keywords

3 QUINUCLIDINYL 4 IODOBENZILATE; 3 QUINUCLIDINYL 4 IODOBENZILATE I 123; IODINE 123; MUSCARINIC M2 RECEPTOR; RADIOLIGAND; UNCLASSIFIED DRUG;

ARTICLE; DRUG RECEPTOR BINDING; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RADIOCHEMISTRY; RADIOIODINATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEREOISOMERISM; THIN LAYER CHROMATOGRAPHY; X RAY CRYSTALLOGRAPHY;

ADULT; BRAIN; HUMANS; IODINE RADIOISOTOPES; ISOTOPE LABELING; MALE; QUINUCLIDINYL BENZILATE; STEREOISOMERISM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030469298     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Gibson RE, Rzeszotarski WJ, Jagoda EM, Francis BE, Reba RC, Eckelman WC. Iodine-125 3-quinuclidinyl 4-iodobenzilate: a high affinity, high specific activity radioligand for the M1 and M2-acetylcholine receptors. Life Sci 1984;34:2287-2296.
2. Gibson RE, Weckstein DJ, Jagoda EM, Rzeszotarski WJ, Reba RC, Eckelman WC. The characteristics of iodine-125 4-IQNB and H-3 QNB in vivo and in vitro. J Nucl Med 1984;25:214-222.
3. Eckelman WC, Eng R, Rzeszotarski WJ, Gibson RE, Francis B, Reba RC. Use of 3-quinuclidinyl 4-iodobenzilate as a receptor binding radiotracer. J Nucl Med 1985; 26:637-642.
4. Gibson RE, Schneidau TA, Cohen VI, et al. In vitro and in vivo characteristics of [iodine-125] 3-(R)-quinuclidinyl (S)-4-iodobenzilate. J Nucl Med 1989;30:1079-1087.
5. 125I]iodobenzilate transport and specific binding to muscarinic acetylcholine receptor in rat brain in vivo: implications for human studies [see comments]. J Cereb Blood Flow Metab 1990;10:781-807.
6. 14C]iodoantipyrine. Am J Physiol 1990;258:H1585-H1598.
7. 125I]4-IQNB is reflected in the in vivo washout of the radioligand from rat brain. Life Sci 1992;50:629-637.
8. Gitler MS, Cohen VI, De la Cruz R, et al. A novel muscarinic receptor ligand which penetrates the blood brain barrier and displays in vivo selectivity for the m2 subtype. Life Sci 1993;53:1743-1751.
9. Hiramatsu Y, Kawai R, Reba RC, Simon TR, Baum BJ, Blasberg RG. Kinetic analysis of rat parotid gland muscarinic receptors in vivo: comparison with brain and heart. Am J Physiol 1993;264:G541-G552.
10. Gitler MS, De la Cruz R, Zeeherg BR, Reba RC. Tritiated QNB displays in vivo selectivity for the m2 subtype. Life Sci 1994;55:1493-1508.
11. Hiramatsu Y, Eckelman WC, Baum BJ. Interaction of iodinated quinuclidinyl benzilate enantiomers with M3 muscarinic receptors. Life Sci 1994;54:1777-1783.
12. Hiramatsu Y, Kawai R, Reba RC, Blasberg RG, Baum BJ. Kinetic analysis of rat exocrine gland muscarinic receptors in vivo. J Pharmacol Exp Ther 1994;269:1205-1212.
13. Hiramatsu Y, Eckelman WC, Carrasquillo JA, et al. Kinetic analysis of muscarinic receptors in human brain and salivary gland in vivo. Am J Physiol 1995;268:R1491-R1499.
14. Eckelman WC, Reba RC, Rzeszotarski WJ, et al. External imaging of cerebral muscarinic acetylcholine receptors. Science 1984;223:291-293.
15. Holman BL, Gibson RE, Hill TC, Eckelman WC, Albert M, Reba RC. Muscarinic acetylcholine receptors in Alzheimer's disease. In vivo imaging with iodine- 123-labeled 3-quinuclidinyl-4-iodobenzilate and emission tomography. JAMA 1985;254: 3063-3066.
16. Weinberger DR, Mann U, Gibson RE, et al. Cerebral muscarinic receptors in primary degenerative dementia as evaluated by SPECT with iodine-123-labeled QNB. Adv Neurol 1990;51:147-150.
17. 123IQNB and single photon emission computed tomography. Arch Neurol 1991;48: 169-176.
18. Weinberger DR, Jones D, Reba RC, et al. A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia. J Neuropsych Clin Neurosci 1992;4:239-248.
19. Weinberger DR, Jones DW, Sunderland T, et al. In vivo imaging of cerebral muscarinic receptors with iodine-123-QNB and SPECT: studies in normal subjects and patients with dementia. Clin Neuropharmacol 1992;15:194A-195A.
20. Wyper DJ, Brown D, Patterson J, et al. Deficits in iodine-labeled 3-quinuclidinyl benzilate binding in relation to cerebral blood flow in patients with Alzheimer's disease. Eur J Nucl Med 1993;20:379-386.
21. Sunderland T, Esposito G, Molchan SE, et al. Differential cholinergic regulation in Alzhiemer's patients compared to controls following chronic blockade with scopolamine: a SPECT study. Psychopharmacol 1995;121:231-241.
22. Lee KS, Gibson RE, Eckelman WC, Reba RC. Radioiodination of a 3-quinuclidinyl benzilate using no-carrier-added concentration of iodine-125/Nal [Abstract]. J Nucl Med 1986;27:(suppl)1045P.
23. Rzeszotarski WJ, Eckelman WC, Francis BE, et al. Synthesis and evaluation of radioiodinated derivatives of 1-azabicyclo[2.2.2]oct-3-yl alpha-hydroxy-alpha-(4-iodophenyl)-alpha- phenylacetate as potential radiopharmaceuticals. J Med Chem 1984;27:156-160.
24. 125I]iodophenyl)-alpha-phenyl acetate as potential radiopharmaceuticals. J Pharm Sci 1989;78:833-836.
25. 123I-QNB, a SPECT agent for cerebral muscarinic acetylcholine receptors in vivo. J Lab Comp Radiopharm 1991;31:45-60.
26. Kabalka GW, Gai YZ, Mathur S. Synthesis of iodine-125-labeled 3-quinuclidinyl 4′-iodobenzilate. Int J Rad Appl Instrum [b] 1989;16:359-360.